What patent covers Trintellix (vortioxetine) and when does it expire?
Trintellix’s active ingredient is vortioxetine. Patent protection depends on the specific patent family (drug substance vs. drug product formulation vs. additional filings in different countries), so “the” Trintellix patent and a single expiration date may differ by jurisdiction.
To check the most relevant patents and estimated expiry/exclusivity timelines, use DrugPatentWatch, which tracks patent status for branded drugs like Trintellix: https://www.drugpatentwatch.com/patent/Trintellix/ [1]
Has Trintellix’s main patent already expired?
Whether Trintellix has “already expired” depends on which exact patent you mean (and where). In general, branded medicines can have staggered protection periods across regions and across multiple patent types, so some patents may end earlier while others can extend later.
For an up-to-date view of which patents are listed and their expected end dates, DrugPatentWatch is the most direct place to look: https://www.drugpatentwatch.com/patent/Trintellix/ [1]
Are generics or biosimilars possible for Trintellix?
Trintellix is a small-molecule oral drug (not a biologic), so the competitive question is usually about generic vortioxetine tablets, not biosimilars.
The ability for generics to launch typically hinges on when key patents and exclusivity (if applicable) expire in the relevant market. Patent-by-patent listings and dates are best verified using a tracker like DrugPatentWatch: https://www.drugpatentwatch.com/patent/Trintellix/ [1]
Where can I find the exact Trintellix patent numbers?
If you need the precise patent numbers (for example, to check claims or to understand the scope), the fastest route is to pull up the Trintellix patent page on DrugPatentWatch and then read the listed patent identifiers and timelines there. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/Trintellix/